Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
06/2014
06/05/2014WO2014083003A1 Pro-cognitive compound
06/05/2014US20140155680 Angiogenesis initiation and growth
06/05/2014US20140155678 Focused radiation for augmenting immune-based therapies against neoplasms
06/05/2014US20140155477 Substituted biaryl sulfonamides and the use thereof
06/05/2014US20140155461 Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases
06/05/2014US20140155456 Use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epileptic drug (saed) in the treatment of epilepsy
06/05/2014US20140155444 Tetrahydronaphthalene derivatives
06/05/2014US20140155442 Anti-obesity agent comprising high-purity epa
06/05/2014US20140155433 Biaryl derivatives as nachr modulators
06/05/2014US20140155431 Modulators of atp-binding cassette transporters
06/05/2014US20140155409 Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
06/05/2014US20140155404 Piperazinylpiperidine derivatives as chemokine receptor antagonists
06/05/2014US20140155401 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands
06/05/2014US20140155393 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
06/05/2014US20140155384 Compounds and methods of treating diabetes
06/05/2014US20140155382 Anti-viral compounds
06/05/2014US20140155367 Compounds and compositions for the treatment of parasitic diseases
06/05/2014US20140155361 Method for treating lung disease
06/05/2014US20140155358 Therapeutic Compounds
06/05/2014US20140155346 Cosmetic and/or dermatological use of oligosaccharide compounds for preventing and treating stretch marks
06/05/2014US20140155338 Use of pde iii inhibitors for the reduction of heart size in mammals suffering from heart failure
06/05/2014US20140155326 Egfr and c-met fibronectin type iii domain binding molecules
06/05/2014US20140155325 Egfr and c-met fibronectin type iii domain binding molecules
06/05/2014US20140155322 Method of Preventing Or Reducing Scarring Of Human Skin
06/05/2014US20140155316 Fibroblast growth factor 1 protein fragments and methods of use
06/05/2014US20140155315 Synthetic linear apelin mimetics for the treatment of heart failure
06/05/2014US20140154340 Methods to treat cancer using cyclosporine and cyclosporine derivatives
06/05/2014US20140154339 Fast Acting Inhibitor of Gastric Acid Secretion
06/05/2014US20140154335 Antimicrobial packaing
06/05/2014US20140154320 Extended-release formulation for reducing the frequency of urination and method of use thereof
06/05/2014US20140154312 Oral targetted drug delivery system
06/05/2014US20140154307 Inhibition of factor b, the alternative complement pathway and methods related thereto
06/05/2014US20140154272 Compound and method for modulating opioid receptor activity
06/05/2014US20140154261 Pharmaceutical composition for treatment and/or prophylaxis of cancer
06/05/2014US20140154246 Cai-based systems and methods for the localized treatment of ocular and other diseases
06/05/2014US20140154244 Methods of Treating Primary Brain Tumors by Administering Letrozole
06/05/2014US20140154243 Specific binding agents to hepatocyte growth factor
06/05/2014US20140154240 Pyrazolo[1,5-a]pyrimidines for antiviral treatment
06/05/2014US20140154232 Use of Pl3K Inhibitors for the Treatment of Obesity, Steatosis and Ageing
06/05/2014US20140154229 Proteolytic extract from bromelain for the treatment of connective tissue disorders
06/05/2014US20140154226 Regeneration and repair of neural tissue using postpartum-derived cells
06/05/2014US20140154214 Selective glucagon-like-peptide-2 (glp-2) analogues
06/05/2014US20140154211 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
06/05/2014US20140154210 Solid Forms of a Thiophosphoramidate Nucleotide Prodrug
06/05/2014US20140154208 Novel [N-Me-4-hydroxyleucine]-9-Cyclosporin Analogues for Treatment and Prevention of Hepatitis C Infection
06/05/2014DE112012002813T5 Kombinationsbehandlung (zB mit ABT-072 oder ABT-333 von DAAs zur Verwendung in der Behandlung von HCV) Combination treatment (eg with ABT-072 or ABT-333 of DAAs for use in the treatment of HCV)
06/04/2014EP2737908A1 Viscoelastic gels in ophthalmic surgery
06/04/2014EP2737904A2 Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury
06/04/2014EP2737902A1 Compositions comprising cimetidine and n,o-carboxymethyl chitosan for the prevention and therapy of pathologies of the skin and the mucous membranes and in the odontostomatological field
06/04/2014EP2737900A1 Ndm inhibitor
06/04/2014EP2737898A1 Compositions comprising Tramadol and Celecoxib in the treatment of pain
06/04/2014EP2736508A1 Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor
06/04/2014EP2736501A1 Intrathecal or epidural administration of 3-[(1s,2s)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol
06/04/2014EP2736491A2 Bepotastine compositions
06/04/2014CN103841969A Treatment and prevention of diseases mediated by microorganisms via drug-mediated manipulation of the eicosanoid balance
06/04/2014CN103830733A Non-invasive green immune self-healing eliminating method for carcinoma lump
06/04/2014CN103830732A Method for treating peritoneal fibrosis
06/04/2014CN103830731A Glucocorticoid/H1 receptor antagonist compound inhalation composition
06/04/2014CN103830730A Budesonide/H1 receptor antagonist compound inhalant
06/04/2014CN103830729A Fluticasone and fluticasone ester/H1 receptor antagonist inhalant
06/04/2014CN103830728A Compound inhalation medicine of ciclesonide and H1 receptor antagonist
06/04/2014CN103830727A Compound inhalation medicine of mometasone furoate and H1 receptor antagonist
06/04/2014CN103830726A Antimicrobial organic nanometer composition and preparation method thereof
06/04/2014CN103830238A Application of five-membered benzoazacyclopiperidine derivative
06/04/2014CN103830208A H1-receptor-antagonist-containing inhalation preparation
06/04/2014CN102698116B Application of lophatherum gracile total flavonoids in preparation of medicine and functional food for preventing and treating myocardial ischemia disease
06/04/2014CN102676516B New use of microRNA 145
06/04/2014CN102552910B Application of extracellular matrix protein 1 and regulator thereof in preparing medicament for diagnosing or treating allergic diseases
06/04/2014CN102026661B Nutrient composition capable of adjusting energy amount, water amount and salt equivalent
06/04/2014CN101780080B Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
06/04/2014CN101708338B Prodrug containing sterides structures and high dispersion preparation thereof
06/03/2014US8741970 Composition and method for the enhancement of the efficacy of drugs
06/03/2014US8741943 Bicyclic compound, production and use thereof
06/03/2014US8741905 Compounds and methods for treating autoimmune diseases
06/03/2014US8741880 Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
06/03/2014US8741876 Therapeutic agent for ulcerative colitis
06/03/2014US8741869 Oligodeoxynucleotide and its use to induce an immune response
06/03/2014US8741351 Microspheres for active embolization
06/03/2014US8741313 Polypeptide vaccine and vaccination strategy against mycobacterium
06/03/2014CA2633356C Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same
06/03/2014CA2486716C Compositions and their uses for alleviating pain
06/03/2014CA2443995C Endothelial cell expression patterns
06/03/2014CA2434490C Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
06/03/2014CA2412764C Stimulation of cellular regeneration and differentiation in the inner ear
06/03/2014CA2395892C Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
06/02/2014DE202014000996U1 Inhibitoren des microRNA-Argonaute Protein-Komplexes Inhibitors of microRNA-Argonaute protein complex
05/2014
05/30/2014WO2014081944A2 Egfr and c-met-fibronectin type iii domain binding molecules
05/30/2014WO2014081029A1 Prophylactic, therapeutic or alleviating agent for peripheral nerve disorders caused by anti-cancer agents
05/30/2014WO2014080162A1 Vip and an alpha-adrenergic blocker for use in the diagnosis of erectile dysfunction and vascular ischaemia
05/30/2014WO2014080161A1 Vip and an alpha-adrenergic blocker for use in the treatment of erectile dysfunction post radical prostatectomy
05/30/2014WO2014079709A1 Use of small molecule inhibitors/activators in combination with (deoxy)nucleoside or (deoxy)nucleotide analogs for treatment of cancer and hematological malignancies or viral infections
05/30/2014WO2014047569A9 Product comprising a nicotine-containing material and an anti-cancer agent
05/29/2014US20140148513 Small molecule therapeutic compounds targeting thioesterase deficiency disorders and methods of using the same
05/29/2014US20140148499 Methods and reagents for efficient control of hiv progression
05/29/2014US20140148494 Spiro-oxindole mdm2 antagonists
05/29/2014US20140148478 Heteroquinoline-3-carboxamides as kcnq2/3 modulators
05/29/2014US20140148476 Methods for treating obesity and disorders associated with hyperlipidemia in a mammal
05/29/2014US20140148473 Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione in treatment of immune-related and inflammatory diseases
05/29/2014US20140148462 Indanyloxydihydrobenzofuranylacetic acids
05/29/2014US20140148459 Matrix metalloproteinase inhibitors
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 1151